Ginkgo Biloba 60mg + Vinpocetine 10mg Tablet | PCD Pharma Franchise in Hyderabad

Ginkgo Biloba 60mg + Vinpocetine 10mg Tablet | Pharma Manufacturing Company in Mumbai

Ginkgo Biloba 60mg + Vinpocetine 10mg Tablet | Neurology Pharma Franchise in Pune

Ginkgo Biloba 60mg + Vinpocetine 10mg Tablet | Pharma Suppliers in Delhi

Ginkgo Biloba 60mg + Vinpocetine 10mg Tablet | Pharma Export Companies in Kolkata
Ginkgo Biloba 60mg + Vinpocetine 10mg Tablet | Franchise Opportunities in Bengaluru

Home/Products /ginkgo-biloba-ip-60mg-vinpocetine-ip-10mg-tablet

Bringcitam G Tablet

Composition : Ginkgo Biloba IP 60mg + Vinpocetine IP 10mg

Dosage Form : Tablet

Packaging Type : Alu ALu

Packaging : 10x10

Price : ₹399/-

Bringcitam G Tablet is a neuroprotective formulation that combines the cognitive-enhancing power of Ginkgo Biloba and Vinpocetine. Ginkgo Biloba is a well-established herbal extract known for its antioxidant properties and its ability to improve cerebral blood flow, memory, and mental clarity. Vinpocetine, a synthetic derivative of the vinca alkaloid, complements Ginkgo Biloba by enhancing brain metabolism, promoting neurovascular protection, and improving oxygen and glucose utilization in the brain. Together, they support enhanced cognitive function, mental alertness, and memory retention, making this combination ideal for patients experiencing age-related cognitive decline or neurological fatigue.

Read More

About the Product

Bringcitam G Tablet is a neuroprotective formulation that combines the cognitive-enhancing power of Ginkgo Biloba and Vinpocetine. Ginkgo Biloba is a well-established herbal extract known for its antioxidant properties and its ability to improve cerebral blood flow, memory, and mental clarity. Vinpocetine, a synthetic derivative of the vinca alkaloid, complements Ginkgo Biloba by enhancing brain metabolism, promoting neurovascular protection, and improving oxygen and glucose utilization in the brain. Together, they support enhanced cognitive function, mental alertness, and memory retention, making this combination ideal for patients experiencing age-related cognitive decline or neurological fatigue.

Bringcitam G Tablet is usually well tolerated. Mild side effects such as headache, dizziness, nausea, or gastrointestinal discomfort may occasionally occur. Rare allergic reactions or skin rashes should be reported to a healthcare provider immediately.

Bringcitam G Tablet is indicated for the management of cognitive impairments, including memory loss, reduced concentration, and age-associated decline in mental performance. It is useful in conditions such as dementia, Alzheimer's disease, vertigo, cerebral insufficiency, and other neurological disorders marked by poor cerebral circulation and oxidative stress. It may also be used as a supportive therapy for individuals recovering from stroke or suffering from chronic fatigue, tinnitus, or mood instability linked to poor brain function.

This product should be used under medical supervision, particularly in patients with bleeding disorders or those on anticoagulant therapy. Not recommended during pregnancy and lactation unless prescribed. Avoid alcohol and inform your doctor about all ongoing medications before starting.

Store in a cool, dry place below 25°C. Keep away from direct sunlight and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation